Pfizer Inc (PFE)

$27.56 +0.34 (1.25%)
Market Cap 156.71B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.43
Forward PE 9.13
Profit Margin 12.42%
Debt to Equity Ratio 0.75
Volume 30,080,400
Avg Vol 39,541,699
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 88%
Beta 0.43
Analysts Sell
Price Target $29.05

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Typecheck
Typecheck Apr. 18 at 7:11 PM
$PFE why bearish sentiment on this board?
1 · Reply
BioRich
BioRich Apr. 18 at 3:53 PM
$CMND Great news from the President today. The sector will get a lot of attention this weekend and into Monday. As a friendly reminder, H.R. 7091 (Expanding Veterans’ Access to Emerging Treatments Act) includes MEAI (which is the primary focus of $CMND). Exciting times folks. https://www.congress.gov/bill/119th-congress/house-bill/7091/text $XBI $PBM $HIGH $PFE
0 · Reply
ajbski
ajbski Apr. 18 at 3:47 PM
$NVAX 's Nuvaxovid showed better tolerability than Moderna’s mNEXSPIKE in head-to-head study. $MRNA $PFE $SNY https://www.globenewswire.com/news-release/2026/04/18/3276558/0/en/press-release-escmid-sanofi-s-nuvaxovid-covid-19-vaccine-showed-better-tolerability-than-mnexspike-in-head-to-head-study.html?_gl=1*v2ieyd*_up*MQ..*_ga*MjU0ODg1NDEzLjE3NzY1MTM3MzQ.*_ga_B6167QB2TF*czE3NzY1MTM3MzMkbzEkZzAkdDE3NzY1MTM3MzkkajU0JGwwJGgw*_ga_ERWPGTJ5X8*czE3NzY1MTM3MzMkbzEkZzAkdDE3NzY1MTM3MzkkajU0JGwwJGgw
0 · Reply
clan
clan Apr. 18 at 3:44 PM
$MNKD $JNJ $PFE 👽 🚫💉 Release the files! #inhalemyinsulin #afrezza #morkfromork
1 · Reply
taxplanr
taxplanr Apr. 18 at 11:01 AM
C19 clot shot stroke cover up $BNTX $MRNA $PFE https://www.instagram.com/reel/DW9mB2uAuMO/?igsh=MTFmZGEwbnZzdXd0Zg==
0 · Reply
Tiger65
Tiger65 Apr. 18 at 10:28 AM
$NVO Sold some strike 25$ Jan28 puts last week. Premiums still quite elevated due to high IV. Company still highly profitable, with growth break comparable to $PFE . Reaction exaggerated. Share price finding its bottom round around 30 - 40 USD in my opinion, due to rebound. If I get assigned, I have a low priced high yeald dividend stock in my portfolio. Trying to copy Warren Buffett’s Coca-Cola trade LOL.
0 · Reply
MildredBlackwella
MildredBlackwella Apr. 18 at 10:21 AM
$OTH https://www.globenewswire.com/news-release/2026/04/16/3275540/0/en/Off-The-Hook-Yachts-Expands-Into-New-Boat-Sales-With-Sportsman-And-Phenom-Brands-Powered-By-Unique-Storage-Ecosystem.html $ALOY $PFE Off The Hook Yachts Expands Into New Boat Sales With Sportsman And Phenom Brands, Powered By Unique Storage Ecosystem https://www.stocktitan.net/news/OTH/off-the-hook-yachts-expands-into-new-boat-sales-with-sportsman-and-aorktbng3ie4.html
0 · Reply
framus_morrigan
framus_morrigan Apr. 18 at 9:52 AM
$PFE 2-month candles chart. That red dotted line is its SMA50. It's the level to beat if you want to see a long term uptrend again. Now it's around 28.9. GL
0 · Reply
DragonAlgo
DragonAlgo Apr. 17 at 11:27 PM
🐉 $PFE CALL — DragonAlgo® Signal Contract: PFE CALL Expiry: 2026-04-17 | Strike: $27.00 | Type: CALL Option Plan (premium): Entry: $0.56 Stop: $0.40 TP1: $0.73 TP2: $0.95 TP3: $1.34 🔗 https://dragonalgo.com
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Apr. 17 at 11:24 PM
$PFE - Pfriendly reminder: VOTE!
0 · Reply
Latest News on PFE
The Big 3: PFE, V, SYF

Apr 16, 2026, 1:01 PM EDT - 2 days ago

The Big 3: PFE, V, SYF

SYF V

Big Pharma Is Turning to China for the Newest Drug Ideas

Apr 10, 2026, 11:00 PM EDT - 8 days ago

Big Pharma Is Turning to China for the Newest Drug Ideas

Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders

Apr 9, 2026, 10:00 AM EDT - 9 days ago

Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders

Why Is Pfizer Stock Dropping Tuesday?

Apr 7, 2026, 1:54 PM EDT - 11 days ago

Why Is Pfizer Stock Dropping Tuesday?

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

Apr 2, 2026, 11:14 AM EDT - 16 days ago

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

NVO LLY

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

Apr 1, 2026, 11:39 AM EDT - 17 days ago

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

BNTX

Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines

Apr 1, 2026, 10:13 AM EDT - 17 days ago

Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

Mar 30, 2026, 10:44 AM EDT - 19 days ago

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

GSK LLY NVO PPH

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

Mar 24, 2026, 10:00 AM EDT - 25 days ago

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

Mar 23, 2026, 12:46 PM EDT - 26 days ago

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

VALN

Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive

Mar 23, 2026, 10:35 AM EDT - 26 days ago

Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive

VALN

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Mar 23, 2026, 9:36 AM EDT - 26 days ago

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

VALN

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Mar 23, 2026, 7:07 AM EDT - 26 days ago

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

VALN

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

Mar 23, 2026, 7:02 AM EDT - 26 days ago

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

VALN

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

Mar 23, 2026, 6:47 AM EDT - 26 days ago

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

VALN

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

Mar 23, 2026, 6:45 AM EDT - 26 days ago

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

VALN

5 ‘Healthy' Dividends Paying Up To 14.1%

Mar 22, 2026, 9:45 AM EDT - 27 days ago

5 ‘Healthy' Dividends Paying Up To 14.1%

ARE BME DOC HQH

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

Mar 20, 2026, 4:30 PM EDT - 4 weeks ago

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

Mar 19, 2026, 6:45 AM EDT - 4 weeks ago

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

TrumpRx lists many medicines at prices higher than paid in UK

Mar 18, 2026, 2:23 PM EDT - 4 weeks ago

TrumpRx lists many medicines at prices higher than paid in UK

ABBV AMGN AZN BMY GILD GSK JNJ

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Mar 17, 2026, 7:49 AM EDT - 4 weeks ago

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Mar 17, 2026, 6:45 AM EDT - 4 weeks ago

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Mar 9, 2026, 7:27 AM EDT - 5 weeks ago

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

Mar 9, 2026, 6:45 AM EDT - 5 weeks ago

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

China approves Pfizer GLP-1 drug for weight management

Mar 6, 2026, 12:40 AM EST - 6 weeks ago

China approves Pfizer GLP-1 drug for weight management

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

Mar 5, 2026, 4:48 PM EST - 6 weeks ago

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

Mar 4, 2026, 8:55 AM EST - 6 weeks ago

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

SMWB

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

Mar 3, 2026, 8:10 AM EST - 6 weeks ago

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

PRGO XRAY

Pfizer CEO flags issues with FDA's vaccine leadership

Mar 2, 2026, 11:14 AM EST - 6 weeks ago

Pfizer CEO flags issues with FDA's vaccine leadership

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

Feb 27, 2026, 10:00 AM EST - 7 weeks ago

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Feb 24, 2026, 2:29 PM EST - 7 weeks ago

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Feb 24, 2026, 7:45 AM EST - 7 weeks ago

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Pfizer in diabetes drug deal with Sciwind Biosciences

Feb 23, 2026, 10:26 PM EST - 7 weeks ago

Pfizer in diabetes drug deal with Sciwind Biosciences

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

Feb 23, 2026, 3:15 PM EST - 7 weeks ago

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

MRK MRNA

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Feb 23, 2026, 10:00 AM EST - 7 weeks ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Is There 25% Downside For Pfizer Stock?

Feb 18, 2026, 12:00 PM EST - 2 months ago

Is There 25% Downside For Pfizer Stock?

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Feb 17, 2026, 6:45 AM EST - 2 months ago

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Prices, pipelines and patent cliffs: Inside pharma's big reset

Feb 13, 2026, 6:13 AM EST - 2 months ago

Prices, pipelines and patent cliffs: Inside pharma's big reset

AMGN LLY NVO

These 32 favorite stocks signal the bull market is running on fumes

Feb 12, 2026, 8:05 AM EST - 2 months ago

These 32 favorite stocks signal the bull market is running on fumes

AAPL ABT ADBE AMGN AVGO BAC BK

Is Pfizer Stock Now A Value Trap?

Feb 11, 2026, 8:56 AM EST - 2 months ago

Is Pfizer Stock Now A Value Trap?

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Feb 10, 2026, 3:20 PM EST - 2 months ago

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

Feb 6, 2026, 2:55 PM EST - 2 months ago

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Feb 6, 2026, 6:45 AM EST - 2 months ago

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Feb 5, 2026, 7:09 PM EST - 2 months ago

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

Feb 3, 2026, 1:27 PM EST - 2 months ago

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

ALT AMGN GPCR LLY NVO VKTX

Silver Surges Over 15%; Pfizer Earnings Top Views

Feb 3, 2026, 12:00 PM EST - 2 months ago

Silver Surges Over 15%; Pfizer Earnings Top Views

Pfizer, Merck report Q4 results: Citi's Geoff Meacham on key takeaways

Feb 3, 2026, 11:17 AM EST - 2 months ago

Pfizer, Merck report Q4 results: Citi's Geoff Meacham on key takeaways

MRK

Pfizer beats quarterly estimates despite Covid product decline - reaffirms modest outlook

Feb 3, 2026, 10:15 AM EST - 2 months ago

Pfizer beats quarterly estimates despite Covid product decline - reaffirms modest outlook

Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops

Feb 3, 2026, 8:50 AM EST - 2 months ago

Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops

Pfizer maps post-Covid reset with obesity trials and deep cost cuts

Feb 3, 2026, 8:17 AM EST - 2 months ago

Pfizer maps post-Covid reset with obesity trials and deep cost cuts

Typecheck
Typecheck Apr. 18 at 7:11 PM
$PFE why bearish sentiment on this board?
1 · Reply
BioRich
BioRich Apr. 18 at 3:53 PM
$CMND Great news from the President today. The sector will get a lot of attention this weekend and into Monday. As a friendly reminder, H.R. 7091 (Expanding Veterans’ Access to Emerging Treatments Act) includes MEAI (which is the primary focus of $CMND). Exciting times folks. https://www.congress.gov/bill/119th-congress/house-bill/7091/text $XBI $PBM $HIGH $PFE
0 · Reply
ajbski
ajbski Apr. 18 at 3:47 PM
$NVAX 's Nuvaxovid showed better tolerability than Moderna’s mNEXSPIKE in head-to-head study. $MRNA $PFE $SNY https://www.globenewswire.com/news-release/2026/04/18/3276558/0/en/press-release-escmid-sanofi-s-nuvaxovid-covid-19-vaccine-showed-better-tolerability-than-mnexspike-in-head-to-head-study.html?_gl=1*v2ieyd*_up*MQ..*_ga*MjU0ODg1NDEzLjE3NzY1MTM3MzQ.*_ga_B6167QB2TF*czE3NzY1MTM3MzMkbzEkZzAkdDE3NzY1MTM3MzkkajU0JGwwJGgw*_ga_ERWPGTJ5X8*czE3NzY1MTM3MzMkbzEkZzAkdDE3NzY1MTM3MzkkajU0JGwwJGgw
0 · Reply
clan
clan Apr. 18 at 3:44 PM
$MNKD $JNJ $PFE 👽 🚫💉 Release the files! #inhalemyinsulin #afrezza #morkfromork
1 · Reply
taxplanr
taxplanr Apr. 18 at 11:01 AM
C19 clot shot stroke cover up $BNTX $MRNA $PFE https://www.instagram.com/reel/DW9mB2uAuMO/?igsh=MTFmZGEwbnZzdXd0Zg==
0 · Reply
Tiger65
Tiger65 Apr. 18 at 10:28 AM
$NVO Sold some strike 25$ Jan28 puts last week. Premiums still quite elevated due to high IV. Company still highly profitable, with growth break comparable to $PFE . Reaction exaggerated. Share price finding its bottom round around 30 - 40 USD in my opinion, due to rebound. If I get assigned, I have a low priced high yeald dividend stock in my portfolio. Trying to copy Warren Buffett’s Coca-Cola trade LOL.
0 · Reply
MildredBlackwella
MildredBlackwella Apr. 18 at 10:21 AM
$OTH https://www.globenewswire.com/news-release/2026/04/16/3275540/0/en/Off-The-Hook-Yachts-Expands-Into-New-Boat-Sales-With-Sportsman-And-Phenom-Brands-Powered-By-Unique-Storage-Ecosystem.html $ALOY $PFE Off The Hook Yachts Expands Into New Boat Sales With Sportsman And Phenom Brands, Powered By Unique Storage Ecosystem https://www.stocktitan.net/news/OTH/off-the-hook-yachts-expands-into-new-boat-sales-with-sportsman-and-aorktbng3ie4.html
0 · Reply
framus_morrigan
framus_morrigan Apr. 18 at 9:52 AM
$PFE 2-month candles chart. That red dotted line is its SMA50. It's the level to beat if you want to see a long term uptrend again. Now it's around 28.9. GL
0 · Reply
DragonAlgo
DragonAlgo Apr. 17 at 11:27 PM
🐉 $PFE CALL — DragonAlgo® Signal Contract: PFE CALL Expiry: 2026-04-17 | Strike: $27.00 | Type: CALL Option Plan (premium): Entry: $0.56 Stop: $0.40 TP1: $0.73 TP2: $0.95 TP3: $1.34 🔗 https://dragonalgo.com
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Apr. 17 at 11:24 PM
$PFE - Pfriendly reminder: VOTE!
0 · Reply
UsingAGodAlgorithm
UsingAGodAlgorithm Apr. 17 at 11:23 PM
$SE (-75% from short entry) We are the best on ST as far as we have seen. Check our profile. We also covered these names . $DE $ARM $PFE $NVO
0 · Reply
markbrogan
markbrogan Apr. 17 at 11:04 PM
$PFE what's with DLS and PFE both up .41 today?
0 · Reply
Skyhigh_69
Skyhigh_69 Apr. 17 at 9:39 PM
$PFE We breakout next week. Road to $35
2 · Reply
TheWinningStock
TheWinningStock Apr. 17 at 9:22 PM
$CRDL <<---another winner! 🤑 https://www.gurufocus.com/news/8776224/cardiol-therapeutics-crdl-receives-buy-rating-from-canaccord-genuity-crdl-stock-news?mobile=true $VXRT $PFE ....
0 · Reply
Micheal_Pothead
Micheal_Pothead Apr. 17 at 8:58 PM
$PFE up on a Friday is crazy talk
1 · Reply
FillSniper42
FillSniper42 Apr. 17 at 7:24 PM
ABTS stock will 5X from here back to $5-$10+ cheapest mining play on the market - Bottomed out near all time low at 1.30 and was 10+ a few months ago - Only droped because of the crypto selloff..now with crypto reversing it will go back to new highs - 2M float so can have explosive moves at any time and they have real bitcoin mining operations across the US. $SNAL $PFE $CRWV $AIXI $GOOGL WL
0 · Reply
biolover
biolover Apr. 17 at 6:51 PM
$VKTX no selling in VK. Look at volume. In terms of BD , Both $ABBV management and $NVO M Large repeated focus on tolerability. Abbv sees it critical and NVO got burned with GI issues more than efficacy. I honestly don’t believe either will acquire structure ( less tolerable than orforglipron) or $KLRA ( Kai 1953 less tolerable than tirzepatide) But what do I know ? $PFE Bourla twisted people minds.
0 · Reply
doubleuptwice
doubleuptwice Apr. 17 at 5:16 PM
$PFE trump say something we have to move today to keep the pattern good….
0 · Reply
doubleuptwice
doubleuptwice Apr. 17 at 5:09 PM
$PFE can we ever just run??
2 · Reply
doubleuptwice
doubleuptwice Apr. 17 at 4:41 PM
$PFE usually that would be it and we reverse red here…. I’m calling 4-5% before close
0 · Reply
Shelz912
Shelz912 Apr. 17 at 4:26 PM
$PFE Friend just Dx w/ Lyme disease.
0 · Reply
doubleuptwice
doubleuptwice Apr. 17 at 4:14 PM
$PFE I’m just an idiot that reads charts. Don’t pay me no mind
2 · Reply